KYNB insider transaction filings

KYNTRA BIO, INC. — 14 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-09. Screen KYNB transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
DeLucia David — Chief Financial Officer11
Wettig Thane — CEO, Director11

Recent Form 4 filings — KYNTRA BIO, INC.

FiledFormInsiderReported transactionsSource
2026-09-094DeLucia David — Chief Financial OfficerTax withholding (F): 22 @ $8.55EDGAR
2026-09-094Wettig Thane — CEO, DirectorTax withholding (F): 209 @ $8.55EDGAR
2026-06-174Ho Maykin — DirectorGrant/award (A): 7,000 (derivative) @ $0EDGAR
2026-06-174Schoeneck James A — DirectorGrant/award (A): 7,000 (derivative) @ $0EDGAR
2026-06-174Kauffman Michael — DirectorGrant/award (A): 7,000 (derivative) @ $0EDGAR
2026-06-174EDWARDS JEFFREY L — DirectorGrant/award (A): 7,000 (derivative) @ $0EDGAR
2026-06-094DeLucia David — Chief Financial OfficerTax withholding (F): 52 @ $6.71EDGAR
2026-06-094Wettig Thane — CEO, DirectorTax withholding (F): 198 @ $6.71EDGAR
2026-05-194/AWettig Thane — CEO, DirectorPurchase (P): 2,800 @ $7.09EDGAR
2026-05-184Wettig Thane — CEO, DirectorPurchase (P): 2,800 @ $7.09EDGAR
2026-03-104DeLucia David — Chief Financial OfficerTax withholding (F): 60 @ $6.84EDGAR
2026-03-104Wettig Thane — CEO, DirectorTax withholding (F): 277 @ $6.84EDGAR
2026-02-054DeLucia David — Chief Financial OfficerGrant/award (A): 26,000 (derivative) @ $0EDGAR
2026-02-054Wettig Thane — CEO, DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR

Recent 8-K events — KYNTRA BIO, INC.

FiledFormItems reportedSource
2026-08-318-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-098-K8.01 — Other EventsEDGAR
2026-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-098-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-03-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-068-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=KYNB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →